Liquid Biopsy Panels

According to the National Comprehensive Cancer Network (NCCN) guidelines liquid biopsy is the most suitable source of sample DNA for Colorectal, Lung and Breast Cancer diagnosis.

Highly sensitive assay panels and robust bioinformatic analysis pipeline was developed to enable cancer diagnosis from as low as 20 ng of ctDNA (Circulating tumor DNA) while minimizing the sequencing noise for VAF detection. Panel has gone through rigorous experimental validation and these are ready to be used for liquid biopsy based cancer diagnosis.

Enquire Now

Available Kits

ctDNA Colorectal Panel

One of the three liquid biopsy based NGS panels, associated with the capture and screening

LEARN MORE

of 16 genes known to be associated with colorectal cancer. The Panel enables SNV and Indel screening in the whole CDS region of these genes with a target size of 18kb. The assay is sensitive enough to reproducibly run with ≥20 ng of cfDNA (Plasma).

ctDNA Breast Panel

The ctDNA Breast panel supports the diagnosis of 27 genes related to breast cancer. The panel covers major mutation

LEARN MORE

classes like SNV and Indel in whole CDS of the 27 genes with the 99kb target size. The assay is sensitive enough to reproducibly run with ≥20 ng of cfDNA (Plasma).

ctDNA Lung Panel

The ctDNA lung panel supports the diagnosis of 28 genes related to lung cancer. The panel covers major mutation classes

LEARN MORE

like SNV and Indel in whole CDS of the 28 genes with the 47kb target size. The assay is sensitive enough to reproducibly run with ≥20 ng of cfDNA (Plasma).